Antimicrobial peptides and methods of use
View Patent ↗Disclosed herein are novel antimicrobial peptides with useful, improved, or superior properties such as antimicrobial activity, specificity, resistance to degradation desirable levels of hemolytic activity, and therapeutic index against a broad range of microorganisms including gram-negative and gram-positive bacteria and other organisms having a cellular or structural component of a lipid bilayer membrane. Also provided are methods of making and using such peptides to control microbial growth and in pharmaceutical compositions for treatment or prevention of infections caused by such microorganisms. Certain peptides result from structure-based rational design relating to antimicrobial peptide V681, with single D-/L-amino acid substitutions or charged residue substitutions in or near the center of the peptide on the nonpolar or polar face. Some peptides contain one or more (or all) amino acids in the D configuration. Compositions disclosed herein have useful clinical potential as antibiotics including broad spectrum antibiotics.
1. A method of increasing antimicrobial activity or decreasing hemolytic activity of an antimicrobial peptide comprising
producing a modified antimicrobial peptide by replacing at least one hydrophobic amino acid residue in a hydrophobic face of the antimicrobial peptide of SEQ ID NO:1 with at least one hydrophilic amino acid residue,
wherein the modified antimicrobial peptide produced is helical in a hydrophobic environment, and disordered in aqueous media.
2. The method of claim 1 , wherein the at least one hydrophilic amino acid residue is an amino acid residue having a negatively-charged side chain.
3. The method of claim 1 , wherein the at least one hydrophilic amino acid residue is an amino acid residue having a positively-charged side chain.
4. The method of claim 3 , wherein the at least one hydrophilic amino acid residue is a lysine amino acid residue.
5. The method of claim 1 , wherein the at least one hydrophilic amino acid residue is selected from the group consisting of D-lysine and D-alanine, and wherein all other amino acids residues in the modified antimicrobial peptide are in the L-enantiomeric form.
6. The method of claim 1 , wherein the modified antimicrobial peptide produced is selected from the group consisting of SEQ ID NO:24 and SEQ ID NO:25.
7. The method of claim 1 , wherein the modified antimicrobial peptide produced is selected from the group consisting of SEQ ID NO:6 and SEQ ID NO:9.
8. The method of claim 1 , wherein the modified antimicrobial peptide produced is selected from the group consisting of SEQ ID NO:10 and SEQ ID NO:11.
9. The method of claim 1 , wherein the producing step further comprises truncating one residue from an end of the antimicrobial peptide of SEQ ID NO:1.
10. The method of claim 1 , wherein the producing step further comprises truncating two residues from an end of the antimicrobial peptide of SEQ ID NO:1.